Dr. Christine Seidman and Kathy Warden Elected to Merck Board of Directors
Dateline City:
KENILWORTH, N.J.
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Dr. Christine (“Kricket”) E. Seidman, professor, Harvard Medical School, and Kathy J. Warden, chairman, chief executive officer and president, Northrop Grumman Corporation, will join the company’s Board of Directors effective March 16, 2020. Dr. Seidman and Ms. Warden will stand for election with the company’s other directors in connection with Merck’s Annual Meeting of Shareholders on May 26, 2020. With the addition of Dr. Seidman and Ms.
Language:
English
Contact:
Media:
Jennifer Mauer
(908) 740-1801
Investors:
Peter Dannenbaum
(908) 740-1037
Ticker Slug:
Ticker:
MRK
Exchange:
NYSE
@Merck
Read Original Article: Dr. Christine Seidman and Kathy Warden Elected to Merck Board of Directors »
